Posted on 6/11/18
Immunomedics Announces Proposed Public Offering of Common Stock
MORRIS PLAINS, N.J., June 11, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced that . . .
Posted on 6/11/18
Optinose Announces Closing of Public Offering
YARDLEY, Pa., June 11, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today the closing of its underwritten public offering of 5,750,000 of its common shares . . .
Posted on 6/11/18
HC2 Sells BeneVir Biopharm To Janssen Biotech For $1.04 Billion
HC2 Holdings, Inc. (NYSE:HCHC), a diversified holding company, announced today that it has completed the sale of BeneVir Biopharm, Inc.,
Posted on 6/11/18
Court Issues Decision in Favor of Eagle Pharmaceuticals Granting Seven Year Orphan Drug Exclusivity for BENDEKA
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) announced today that the U.S. District Court for the District of Columbia (the Court) has issued a decision requiring . . .
Posted on 6/10/18
Johnson & Johnson: High-Quality Value Hiding In Plain Sight
Johnson & Johnson (JNJ) beat on both its top and bottom lines during its most recent quarter, but shares remain stagnant:Shares are still in "correction mode" . . .
Posted on 6/10/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 7, 2018 it approved non-statutory stock options to purchase an aggregate of 134,450 shares of its . . .
Posted on 6/10/18
Oncobiologics Closes Second Tranche of $15 Million Private Placement
CRANBURY, N.J., June 08, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it has closed on the second, and final, tranche of a $15.0 . . .
Posted on 6/10/18
Johnson & Johnson: Value In Plain Sight
Johnson & Johnson (JNJ) beat on both its top and bottom lines during its most recent quarter, but shares remain stagnant:Shares are still in "correction mode" . . .
Posted on 6/8/18
Celgene (CELG) Presents At Jefferies 2018 Global Healthcare Conference - Slideshow
The following slide deck was published by Celgene Corporation in conjunction with this event. 118READ FULL ARTICLE HERE
Posted on 6/8/18
Verrica Pharmaceuticals Aims For $75 Million U.S. IPO
Verrica Pharmaceuticals (VRCA) intends to raise $75 million in an IPO of its common stock, per an SEC filing.
Posted on 6/8/18
Pharmacy Times Ranks No. 1 Among Total Pharmacists
CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times®, the leading media resource for pharmacists and the pharmacy industry, is the most-read pharmacy journal among total pharmacists, according the 2018 Kantar . . .
Posted on 6/8/18
ADMA Biologics Announces Proposed Public Offering of Common Stock
RAMSEY, N.J. and BOCA RATON, Fla., June 07, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) announced today that it has commenced an underwritten public offering . . .
Posted on 6/8/18
Agile Therapeutics Provides Corporate Update
PRINCETON, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women’s healthcare company, today announced several key corporate updates: Formal dispute resolution request . . .
Posted on 6/7/18
PANTHERx Specialty Pharmacy Selected by Ultragenyx to Distribute Crysvita
PANTHERx Specialty Pharmacy, THE Rare Disease Specialty Pharmacy, announced that it has been selected by Ultragenyx Pharmaceutical, Inc. to distribute Crysvita (burosumab-twza), the very first FDA-approved . . .
Posted on 6/7/18
Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania
NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation (NASDAQ: OPHT) announced today that it has entered into an exclusive global license agreement with the University of Florida Research Foundation and . . .
Posted on 6/6/18
Noble Life Sciences Selects Comprehensive Suite of Preclinical Software Solutions from Instem
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global life sciences market, is pleased to announce that Noble Life Sciences, Inc. (Noble) has . . .
Posted on 6/6/18
Pfizer to Expand Venture Investing with $600 Million Commitment to Pfizer Ventures
Pfizer Inc. (NYSE:PFE) today announced it plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures,
Posted on 6/5/18
Madrigal Pharmaceuticals Proposes Public Offering of Common Stock
CONSHOHOCKEN, Pa., June 05, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates . . .
Posted on 6/5/18
Teligent Closes $25 Million Secured Credit Facility
BUENA, N.J., June 05, 2018 (GLOBE NEWSWIRE) -- TELIGENT, Inc. (NASDAQ:TLGT) Teligent, Inc. announced today that it has entered into a Credit Agreement with certain funds managed . . .
Posted on 6/5/18
Celgene: Mr. Market Is Knocking, Presenting A Buying Opportunity
Founded in 1986, Celgene (Nasdaq: CELG) is a leading research company for medicines treating cancer and inflammatory disorders. For many years, Celgene was one of the . . .
Posted on 6/5/18
Merck Steals The Show At ASCO 2018 With Impressive Front-Line Lung Cancer Data
Recently, Merck (MRK) presented results from two late-stage trials in patients with non-small cell lung cancer (NSCLC) that were impressive. One late-stage study posted positive results . . .
Posted on 6/5/18
Could Celgene Shake Up the CAR-T Market?
The current CAR-T party of two might have a couple of new companions on the way. And those new entrants could bring some excitement to the . . .
Posted on 6/5/18
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WAYNE, Pa., June 04, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated therapies . . .
Posted on 6/5/18
Optinose Announces Launch of Public Offering of Common Stock
YARDLEY, Pa., June 04, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today that it has filed a registration statement on Form S-1 with the U.S. . . .
Posted on 6/4/18
PENTAX Medical Enters Into Exclusive Distribution Agreement With CapsoVision in USA
PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy solutions, announced today an exclusive distribution agreement with CapsoVision for their CapsoCam Plus Capsule Endoscopy . . .

